$1.30
-0.05-3.70%
Pre-Market: 8:53 AM EDT
Comments
Loading...
Latest Humacyte Stock News | NASDAQ:HUMA | Benzinga
Get the latest news on Humacyte stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Humacyte performance
Categories: All
Monday, March 31, 2025
Friday, March 28, 2025
Thursday, March 27, 2025
Wednesday, March 26, 2025
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Why Humacyte (HUMA) Stock Is Falling Sharply
- D. Boral Capital Maintains Buy on Humacyte, M...
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Humacyte shares are trading lower after the c...
- Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- US Stocks Likely To Open Lower After 3-Day Advance: Market Is Looking 'More Balanced' And Gone From 'Above-Trend To On-Trend,' Says Expert
- Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
- Reported Earlier, Humacyte Prices $50M Public...
Tuesday, March 25, 2025
Wednesday, March 12, 2025
Monday, March 10, 2025
Friday, March 07, 2025
Monday, March 03, 2025
Thursday, February 27, 2025
Wednesday, February 26, 2025
Tuesday, January 28, 2025
Tuesday, January 21, 2025
Monday, January 13, 2025
Monday, December 23, 2024
Friday, December 20, 2024
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Dow Surges Over 600 Points, Gold Jumps 1.5%
- Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher
- Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday
- Spotlight on Humacyte: Analyzing the Surge in Options Activity
- D. Boral Capital Maintains Buy on Humacyte, M...
- Humacyte shares are trading higher after the ...
- Why Is Bioengineered Human Tissue-Focused Humacyte Stock Surging On Friday?
- Market-Moving News for December 20th
- HC Wainwright & Co. Reiterates Buy on Humacyt...
- Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
- US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone'
- Reported Earlier, FDA Approves Humacyte's SYM...